Investing.com - GlycoMimetics reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
GlycoMimetics announced earnings per share of $-0.160 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.250 on revenue of $0.
GlycoMimetics 's are down 0.45% and is trading at $0.740 , still down 67.26% from its 52 week high of $2.26 set on Friday, November 12, 2021.
GlycoMimetics shares gained 7.65% to trade at $0.740 in intra-day trade the report.
GlycoMimetics follows other major Healthcare sector earnings this month
GlycoMimetics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar